Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Bloomfield

Showing results (121-130 of 289) with videos related to

Pageof 29
Sort By:
Cancer|July 1, 1976
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPPC D Bloomfield, R B Weiss, I Fortuny, et al.
Cancer|March 1, 1974
Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomasC D Bloomfield, A Goldman, F Dick, et al.
Leukemia|January 1, 1987
Bone marrow cytogenetics: the lineage of dividing cells changes during the first few hours in cultureM Keinänen, S Knuutila, C D Bloomfield, et al.
The Journal of Clinical Investigation|December 1, 1973
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's diseaseK J Gajl-Peczalska, J A Hansen, C D Bloomfield, et al.
Clinical and Experimental Immunology|August 1, 1974
B-cell markers on lymphoblasts in acute lymphoblastic leukaemiaK J Gajl-Peczalska, C D Bloomfield, M E Nesbit, et al.
Cancer Treatment Reports|September 1, 1977
Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
Leukemia|February 3, 1998
Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The NetherlandsB A van der Reijden, C D Bloomfield, I P Touw, et al.
Archives of Internal Medicine|June 1, 1981
Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisoneG E Gibbs, B A Peterson, B J Kennedy, et al.
Leukemia|June 1, 1989
Human bone marrow cytogenetics: growth factors stimulate metaphases for specific lineagesM Keinänen, C D Bloomfield, J Machnicki, et al.
Cancer Treatment Reports|November 1, 1976
Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemiaN K Ramsay, P F Coccia, W Krivit, et al.
Pageof 29

Showing results (121-130 of 289) with videos related to

Sort By:
Pageof 29
Cancer|July 1, 1976
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPPC D Bloomfield, R B Weiss, I Fortuny, et al.
Cancer|March 1, 1974
Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomasC D Bloomfield, A Goldman, F Dick, et al.
Leukemia|January 1, 1987
Bone marrow cytogenetics: the lineage of dividing cells changes during the first few hours in cultureM Keinänen, S Knuutila, C D Bloomfield, et al.
The Journal of Clinical Investigation|December 1, 1973
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's diseaseK J Gajl-Peczalska, J A Hansen, C D Bloomfield, et al.
Clinical and Experimental Immunology|August 1, 1974
B-cell markers on lymphoblasts in acute lymphoblastic leukaemiaK J Gajl-Peczalska, C D Bloomfield, M E Nesbit, et al.
Cancer Treatment Reports|September 1, 1977
Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphomaC D Bloomfield, J H Kersey, R D Brunning, et al.
Leukemia|February 3, 1998
Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The NetherlandsB A van der Reijden, C D Bloomfield, I P Touw, et al.
Archives of Internal Medicine|June 1, 1981
Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisoneG E Gibbs, B A Peterson, B J Kennedy, et al.
Leukemia|June 1, 1989
Human bone marrow cytogenetics: growth factors stimulate metaphases for specific lineagesM Keinänen, C D Bloomfield, J Machnicki, et al.
Cancer Treatment Reports|November 1, 1976
Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemiaN K Ramsay, P F Coccia, W Krivit, et al.
Pageof 29